Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-26

Clinical Trial Results: Dusquetide for the Treatment of Behcet's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results evaluating dusquetide for Behçet disease have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dusquetide (dusquetide)

Snippet

Sponsor: Soligenix | Conditions: Behçet Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-08-26